ENTRY       D09727                      Drug
NAME        Insulin degludec (USAN/INN);
            Insulin degludec (genetical recombination) (JAN);
            Tresiba (TN)
PRODUCT     INSULIN DEGLUDEC (Novo Nordisk Pharma)
            TRESIBA (A-S Medication Solutions)
            TRESIBA (Novo Nordisk)
FORMULA     C274H411N65O81S6
EXACT_MASS  6099.8364
MOL_WEIGHT  6103.972
SEQUENCE    (A chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
            Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys
            (Amide bridge: 29-C)
            (B chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
            Gln Leu Glu Asn Tyr Cys Asn
            (Disulfide bridge: 6-11, A7-B7, A19-B20)
            (C chain)
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG01636  Insulin preparation
              DG01797  Insulin analog, long-acting
REMARK      Therapeutic category: 2492
            ATC code: A10AE06
            Product: D09727<JP/US>
            Product (mixture): D10570<JP> D11567<JP/US>
EFFICACY    Antidiabetic, Insulin receptor agonist
  DISEASE   Diabetes mellitus [DS:H00408 H00409]
COMMENT     Insulin analog
            Treatment of diabetes
TARGET      INSR (CD220) [HSA:3643] [KO:K04527]
  PATHWAY   hsa04910(3643)  Insulin signaling pathway
            hsa04930(3643)  Type II diabetes mellitus
INTERACTION  
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10A INSULINS AND ANALOGUES
                A10AE Insulins and analogues for injection, long-acting
                 A10AE06 Insulin degludec
                  D09727  Insulin degludec (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Insulins
               Insulin, Long-acting
                Insulin Degludec
                 D09727  Insulin degludec (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D09727  Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01636  Insulin preparation
               DG01797  Insulin analog, long-acting
                D09727  Insulin degludec
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01636  Insulin preparation
               D09727  Insulin degludec
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                INSR (CD220)
                 D09727  Insulin degludec (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09727
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09727
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09727
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09727
DBLINKS     CAS: 844439-96-9
            PubChem: 124490467
///
